News Arena

Join us

Searched Tag: covaxin
Controversial Covaxin study faces retraction after ICMR objection. Image X.

ICMR demands retraction of erroneous Covaxin research

May 20, 2024, 05:43 AM - 3 mins read

The Indian Council of Medical Research (ICMR) has disassociated itself from a study on the Covaxin vaccine, citing serious methodological flaws and an erroneous acknowledgment of ICMR's support.

Read more
Bharat Biotech has reiterated the robust safety profile of its anti-COVID-19 vaccine, Covaxin, following a study by Banaras Hindu University (BHU) indicating that nearly one-third of 926 individuals who received the vaccine reported 'adverse events of special interest' (AESI).

Bharat Biotech defends Covaxin's safety amid BHU study findings

May 17, 2024, 12:00 AM - 2 mins read

The BHU study, conducted between January 2022 and August 2023, found that serious AESIs, including stroke and Guillain-Barre syndrome, were reported in 1 percent of the individuals. The study highlighted that nearly 50 percent of participants experienced infections during the follow-up period, predominantly viral upper respiratory tract infections.

Read more
Covaxin is Very Safe Reaffirms Bharat Biotech. Image X.

Covaxin prioritises 'Safety First', says Bharat Biotech amid International Vaccine's safety discussions

May 2, 2024, 07:26 AM - 2 mins read

Amid concerns surrounding the AstraZeneca-Oxford COVID-19 vaccine, Bharat Biotech, the developer of Covaxin, underscores its commitment to safety, emphasising that Covaxin was developed with a primary focus on safety first.

Read more

TOP CATEGORIES

  • Nation

QUICK LINKS

About us Rss FeedSitemapPrivacy PolicyTerms & Condition
logo

2024 News Arena India Pvt Ltd | All rights reserved | The Ideaz Factory